Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -179,200 | -99,968 | -340,414 | -237,785 | -154,637 |
| Depreciation Amortization | 6,584 | 4,015 | 17,186 | 13,962 | 9,607 |
| Accounts payable and accrued liabilities | -3,233 | 1,057 | 4,868 | 1,930 | 917 |
| Other Working Capital | 3,063 | 7,422 | 3,897 | -7,106 | -14,893 |
| Other Operating Activity | 44,290 | 20,835 | 93,944 | 70,576 | 48,238 |
| Operating Cash Flow | $-128,496 | $-66,639 | $-220,519 | $-158,423 | $-110,768 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,323 | -1,035 | -5,191 | -3,499 | -3,276 |
| Purchase Of Investment | -170,514 | -35,094 | -248,109 | -200,318 | -150,864 |
| Sale Of Investment | 301,932 | 149,064 | 359,459 | 260,379 | 185,797 |
| Investing Cash Flow | $130,095 | $112,935 | $106,159 | $56,562 | $31,657 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 91,255 | 1,731 | 2,950 | 2,904 | 1,838 |
| Financing Cash Flow | $91,255 | $1,731 | $2,950 | $2,904 | $1,838 |
| Beginning Cash Position | 72,196 | 72,196 | 183,606 | 183,606 | 183,606 |
| End Cash Position | 165,050 | 120,223 | 72,196 | 84,649 | 106,333 |
| Net Cash Flow | $92,854 | $48,027 | $-111,410 | $-98,957 | $-77,273 |
| Free Cash Flow | |||||
| Operating Cash Flow | -128,496 | -66,639 | -220,519 | -158,423 | -110,768 |
| Capital Expenditure | -1,323 | -1,035 | -5,191 | -3,499 | -3,276 |
| Free Cash Flow | -129,819 | -67,674 | -225,710 | -161,922 | -114,044 |